相似文献
1
It Is Time to Close the Gap in Cancer Care.
JCO Glob Oncol. 2023 Jan;9:e2200429. doi: 10.1200/GO.22.00429.
2
Racial disparities in cancer care: can we close the gap?
Lancet Oncol. 2021 Dec;22(12):1643. doi: 10.1016/S1470-2045(21)00669-0.
3
Billions of dollars needed to close global spending gap on cancer care.
BMJ. 2009 Aug 28;339:b3499. doi: 10.1136/bmj.b3499.
4
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap.
JCO Glob Oncol. 2022 Oct;8:e2200182. doi: 10.1200/GO.22.00182.
5
Cancer genomics and clinical practice: how can we close the gap more quickly?
Curr Opin Obstet Gynecol. 2017 Feb;29(1):1-3. doi: 10.1097/GCO.0000000000000341.
6
Teens and cancer. The care gap.
Minn Med. 2010 Oct;93(10):7.
7
Addressing a Core Gap in Cancer Care - The NCI Moonshot Program to Help Oncology Patients Stop Smoking.
N Engl J Med. 2019 Feb 7;380(6):512-515. doi: 10.1056/NEJMp1813913. Epub 2019 Jan 2.
8
Closing the gap in cancer care in Kenya in 2022.
Lancet Oncol. 2022 Jun;23(6):715-716. doi: 10.1016/S1470-2045(22)00087-0. Epub 2022 May 9.
9
The cancer gap. No two cancers are alike. But what will it take to give every patient equal care?
Time. 2015 Mar 30;185(11):42-7.
10
Development of cancer support services for patients and their close ones from the Cancer Society of Finland's perspective.
Int J Qual Stud Health Well-being. 2021 Dec;16(1):1915737. doi: 10.1080/17482631.2021.1915737.
引用本文的文献
1
Trends and inequalities in gastrointestinal cancer care quality from 1990 to 2021: A population-based analysis of the Global Burden of Disease Study 2021.
Medicine (Baltimore). 2025 Aug 1;104(31):e43569. doi: 10.1097/MD.0000000000043569.
2
Probiotics and Cancer: Mechanistic Insights and Organ-Specific Impact.
Biomolecules. 2025 Jun 16;15(6):879. doi: 10.3390/biom15060879.
3
Cytotoxicity and molecular docking analysis of phytochemicals from with protein target 3CZH in breast cancer management.
Bioinformation. 2024 Dec 31;20(12):2062-2068. doi: 10.6026/9732063002002062. eCollection 2024.
4
Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications.
Eur J Med Res. 2025 Mar 14;30(1):169. doi: 10.1186/s40001-025-02401-0.
5
Global professional issues in radiation therapy: Collaboration, adaptation and innovation.
Tech Innov Patient Support Radiat Oncol. 2024 Dec 31;33:100298. doi: 10.1016/j.tipsro.2024.100298. eCollection 2025 Mar.
6
Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation.
BMJ Oncol. 2023 Nov 20;2(1):e000195. doi: 10.1136/bmjonc-2023-000195. eCollection 2023.
7
Artificial Intelligence and Cancer Health Equity: Bridging the Divide or Widening the Gap.
Curr Oncol Rep. 2025 Feb;27(2):95-111. doi: 10.1007/s11912-024-01627-1. Epub 2025 Jan 3.
8
Equity in cancer care: mixed methods clinical utility analysis of the Nursing Equity Assessment Tool (NEAT) to identify disadvantage in newly diagnosed cancer patients.
Support Care Cancer. 2024 Dec 30;33(1):60. doi: 10.1007/s00520-024-09094-x.
9
Recapitulating the potential contribution of protein S-palmitoylation in cancer.
Cancer Metastasis Rev. 2024 Dec 27;44(1):20. doi: 10.1007/s10555-024-10217-3.
10
Understanding the effectiveness and quality of virtual cancer multidisciplinary team meetings (MDTMs): a systematic scoping review.
BMC Health Serv Res. 2024 Nov 27;24(1):1481. doi: 10.1186/s12913-024-11984-z.
本文引用的文献
1
Cancer statistics for African American/Black People 2022.
CA Cancer J Clin. 2022 May;72(3):202-229. doi: 10.3322/caac.21718. Epub 2022 Feb 10.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Disparities in Cancer-Specific Survival Between Māori and Non-Māori New Zealanders, 2007-2016.
JCO Glob Oncol. 2020 Jun;6:766-774. doi: 10.1200/GO.20.00028.
4
Emerging cancer incidence, mortality, hospitalisation and associated burden among Australian cancer patients, 1982 - 2014: an incidence-based approach in terms of trends, determinants and inequality.
BMJ Open. 2019 Dec 15;9(12):e031874. doi: 10.1136/bmjopen-2019-031874.
5
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11.
6
2016 President's Plenary International Psycho-Oncology Society: challenges and opportunities for growing and developing psychosocial oncology programmes worldwide.
Psychooncology. 2017 Sep;26(9):1231-1238. doi: 10.1002/pon.4471. Epub 2017 Jul 26.
7
Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries.
J Clin Oncol. 2016 Jan 1;34(1):6-13. doi: 10.1200/JCO.2015.62.2860. Epub 2015 Nov 17.
8
Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study.
Lancet Oncol. 2015 Nov;16(15):1483-1492. doi: 10.1016/S1470-2045(15)00232-6. Epub 2015 Oct 22.
9
Geographic disparities in prostate cancer outcomes--review of international patterns.
Asian Pac J Cancer Prev. 2015;16(3):1259-75. doi: 10.7314/apjcp.2015.16.3.1259.
10
Challenges of cancer control in developing countries: current status and future perspective.
Future Oncol. 2011 Oct;7(10):1213-22. doi: 10.2217/fon.11.101.
Zotero 插件